Last reviewed: June 8, 2026
Last updated: June 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide injection has become one of the most researched weight loss medications in recent years, with multiple large-scale trials documenting its safety profile. The medication works by activating GLP-1 receptors in the brain and pancreas, reducing appetite and improving blood sugar control. Understanding how semaglutide functions and its real-world safety data can help you make an informed decision about whether it aligns with your weight loss goals.
How Semaglutide Injection Works for Weight Loss
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of medications originally developed to treat type 2 diabetes. When injected once weekly, semaglutide mimics the natural GLP-1 hormone, which signals fullness to your brain and slows stomach emptying. This dual mechanism reduces overall calorie intake and helps stabilize energy levels throughout the day. The medication also improves insulin sensitivity, which can support more sustainable weight loss over time.
Clinical trials have shown that people using semaglutide lose significantly more weight than those on diet and exercise alone. In the STEP trials, participants lost an average of 15-18% of their body weight over 68 weeks, with some losing over 20% when combined with lifestyle modifications. The weight loss occurs gradually over months, allowing your body to adapt and helping preserve lean muscle mass compared to rapid dieting alone.
Safety Profile of Semaglutide Injection Based on Clinical Evidence
Large randomized controlled trials involving over 4,500 participants have established semaglutide's overall safety for weight management in non-diabetic individuals. The most common side effects are gastrointestinal-related—including nausea, vomiting, diarrhea, and constipation—which typically occur during dose escalation and often diminish as your body adjusts. Serious adverse events occur rarely and at similar rates to placebo groups in clinical studies. Most individuals who experience mild side effects find they resolve within the first few weeks of therapy.
Semaglutide has been administered to millions of patients globally since its approval for diabetes in 2017 and weight management in 2021. Real-world safety monitoring continues to show that the medication is well-tolerated at therapeutic doses when prescribed appropriately. Your healthcare provider will assess your individual health history and adjust your dose gradually—PlexusDx customers start at the lowest dose and only increase if tolerated—to minimize discomfort and maximize benefits.
Potential Side Effects and How to Manage Them
Gastrointestinal side effects represent the primary concern for most people starting semaglutide injection. Nausea affects 25-40% of users during initial weeks, but typically peaks in the first month and improves significantly by week 4-6. Vomiting, diarrhea, and constipation occur less frequently but can be managed through dietary adjustments—eating smaller, lower-fat meals and staying hydrated helps many patients. Ginger supplements, eating bland foods, and spreading eating throughout the day have anecdotally helped some users reduce nausea severity.
Rarer side effects include pancreatitis symptoms (severe abdominal pain), gallbladder issues, and thyroid concerns in susceptible individuals. Rapid heartbeat and dizziness can occur if blood sugar drops too quickly, particularly if you take diabetes medications alongside semaglutide. PlexusDx recommends discussing your complete medication list and personal health history with a licensed provider before starting therapy. If you experience persistent vomiting, severe abdominal pain, or signs of dehydration, stop the injection and contact your healthcare provider immediately.
Who Should and Shouldn't Use Semaglutide Injection
Semaglutide injection is appropriate for adults with a BMI of 27 or higher with weight-related conditions, or BMI of 30 or higher regardless of comorbidities. You are a good candidate if you commit to ongoing lifestyle changes—the medication works best when combined with balanced nutrition and regular movement. People with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN2) should not use semaglutide due to animal study concerns. Pregnancy, nursing, and severe kidney or liver disease are also contraindications that your PlexusDx provider will screen for.
Individuals taking insulin or sulfonylurea medications for diabetes may require dose adjustments to prevent low blood sugar while on semaglutide. Those with a history of pancreatitis, severe gastroparesis, or severe diabetic retinopathy should discuss risks with their provider before starting. PlexusDx's initial consultation helps identify whether semaglutide or an alternative GLP-1 medication like tirzepatide better matches your medical profile and health goals.
PlexusDx Semaglutide: Compounded, Accessible, Personalized
PlexusDx sources semaglutide injection from licensed 503A compounding pharmacies that meet rigorous pharmaceutical standards. Compounding allows for dose flexibility and customization that mass-produced formulations cannot provide, meaning your dose can increase gradually without your price increasing—PlexusDx charges a flat $149/month starting rate regardless of dose level. HSA and FSA accounts are eligible, and no insurance or membership fee is required, making treatment accessible across all 50 states.
The Precision Peptide Genetic Test offers an optional $99 add-on after your first month of treatment, mapping 14 metabolic pathways and 150+ genetic insights related to GLP-1 signaling and peptide responsiveness. Key genetic variants like GLP1R rs6923761 and GIPR rs1800437 influence how your body responds to semaglutide, helping PlexusDx providers fine-tune your treatment plan for optimal outcomes. This personalized approach ensures you receive a medication and dose strategy tailored to your unique biology, not a one-size-fits-all protocol.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded semaglutide from PlexusDx as safe as brand-name versions?
Yes. PlexusDx sources compounded semaglutide exclusively from licensed 503A compounding pharmacies, which operate under strict FDA oversight and pharmaceutical standards identical to commercial manufacturers. The active pharmaceutical ingredient is the same; compounding simply allows dose customization. All PlexusDx medications undergo quality verification before dispensing.
How much weight can I expect to lose with semaglutide injection?
Clinical trials show average weight loss of 15-18% of body weight over 68 weeks when combined with lifestyle changes. Individual results vary based on genetics, diet adherence, and activity level. The Precision Peptide Genetic Test can reveal your genetic predisposition to GLP-1 pathway responsiveness, helping predict your likely response trajectory.
What happens if I experience severe nausea on semaglutide?
Contact your PlexusDx provider immediately if nausea is severe or persistent beyond week 4. Your dose may be temporarily reduced or paused to allow adjustment. Dietary modifications (smaller, lower-fat meals) and hydration often help. If nausea doesn't improve, your provider may recommend an alternative GLP-1 medication like tirzepatide, which has a different side effect profile.
Do I need to check for drug interactions before starting semaglutide?
Yes. Semaglutide can interact with diabetes medications (insulin, sulfonylureas) and medications that slow digestion. PlexusDx requires a complete medication history during your consultation to screen for interactions and adjust your treatment plan accordingly. Always disclose all supplements and prescription medications.
How does the Precision Peptide Genetic Test help personalize my semaglutide treatment?
The test analyzes variants in GLP1R, GIPR, FTO, MC4R, and 10 additional pathways involved in appetite and weight regulation. If you carry specific variants, your body may respond more strongly to semaglutide or may benefit from a dual-compound approach like GLP-Squared. This insight helps your PlexusDx provider select the optimal medication and dosing strategy for your genetics.
Is semaglutide injection covered by insurance through PlexusDx?
PlexusDx does not require insurance; treatment is self-pay at $149/month flat rate starting price. However, your HSA or FSA account can be used to pay for medication and the Precision Peptide Genetic Test, offering tax-advantaged savings. This direct-pay model eliminates prior authorization delays and ensures immediate access across all 50 states.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Does GLP-1 Lower Blood Pressure? Understanding the Connection Between GLP-1 Agonists and Hypertension
Can You Take Vitamins with Semaglutide for Optimal Weight Loss?